# FDA Inspection 1142760 - Biolife Plasma Services - May 20, 2021

Source: https://www.keypedia.com/records/fda_inspections/biolife-plasma-services/ada38e4e-1c15-4c4b-b05a-627f6037732d
Source feed: FDA_Inspections

> FDA Inspection 1142760 for Biolife Plasma Services on May 20, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1142760
- Company Name: Biolife Plasma Services
- Inspection Date: 2021-05-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1013345 - 2017-04-27](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services/38a197c7-5140-42fe-8ac4-3a99920e605b)
- [FDA Inspection 868868 - 2014-03-07](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services/1e7f651c-88a3-43c4-ae0c-45b0650658d6)
- [FDA Inspection 770123 - 2012-02-28](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services/34ac9c29-072d-4640-aa66-959bfe9a298f)
- [FDA Inspection 653623 - 2010-03-23](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services/7693aca2-5b83-4abc-96b8-2137faf7b905)

Company: https://www.keypedia.com/companies/biolife-plasma-services/d814d823-88f6-4055-9672-3a43879575ce

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d